Carregant...
Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges
Oncolytic viruses have emerged as a promising strategy for cancer therapy due to their dual ability to selectively infect and lyse tumor cells and to induce systemic anti-tumor immunity. Among various candidate viruses, coxsackievirus group B (CVBs) have attracted increasing attention in recent year...
Guardat en:
| Publicat a: | Viruses |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8227215/ https://ncbi.nlm.nih.gov/pubmed/34198859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13061082 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|